-The United Nations The United Nations today launched the Zero Hunger Challenge in Asia and the Pacific, calling on governments, farmers, scientists, business, civil society and consumers to work together to end hunger in the region where the majority of the world's undernourished people live. "Sustainable development and inclusive growth will not happen on empty stomachs," said Noeleen Heyzer, Executive Secretary of the UN Economic and Social Commission for Asia and the...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The United Nations A sharp surge in the price of dairy products pushed the overall costs of food one percentage point higher in March, the United Nations reported today, while world wheat production remained on track to reach its second highest level ever, barring adverse weather. Releasing its latest monthly Food Price Index (FPI), the UN Food and Agriculture Organization (FAO) said the dairy component of the index, which carries a 17...

-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...

-The Business Standard Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and patients' associations are in celebration mood. D G Shah, secretary general, The Indian Pharmaceutical Alliance (IPA), comprising leading research-based Indian pharma companies, said,...